Signos
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $37M
Investors
- 7
About Signos
Signos, Inc. is a US-based company focused on continuous glucose monitoring technology that helps individuals understand their metabolism and achieve healthier dietary choices. Founded in 2020 in Burlingame, US, Signos, Inc. specializes in metabolic health solutions. The company is co-founded by Pierre Wehbe, Sharam Fouladgar-Mercer, and William Dixon, with Sharam Fouladgar-Mercer serving as the CEO. In May 2026, Signos, Inc. Signos provides advanced continuous glucose monitoring (CGM) technology designed to assist users in tracking their metabolic responses to food. Their primary offering integrates the Dexcom G7 sensor with the Signos app, delivering real-time glucose readings and personalized dietary feedback. The platform is aimed at health-conscious consumers focused on weight management and improved metabolic health, operating in key markets including the United States. Signos generates revenue through a subscription model, offering users access to its mobile application, personalized nutrition guidance, and essential hardware like the Dexcom G7 sensor. Membership plans are tailored for individual consumers, emphasizing long-term health and wellness, and facilitate direct-to-consumer transactions with their comprehensive glucose monitoring and coaching solutions.
Who invested in Signos
7 investors across 3 rounds
See all investors in Signos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Signos
Who invested in Signos?
Signos has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Signos raised?
Signos has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Signos last raise money?
Signos's most recent round on record is a Series B, in Jun 2023.
What does Signos do?
Signos is a healthcare it company.
Where is Signos headquartered?
Signos is headquartered in Burlingame, US.
Which VCs invest in companies like Signos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Signos's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Signos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.